Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 1
1951 1
1956 1
1968 2
1970 1
1973 2
1975 1
1977 1
1978 4
1979 1
1981 3
1982 1
1984 3
1985 1
1986 1
1987 1
1988 1
1989 3
1990 1
1991 1
1995 1
1998 1
1999 2
2000 1
2001 3
2003 1
2004 1
2005 1
2006 4
2007 3
2008 3
2009 3
2010 4
2011 5
2012 3
2013 8
2014 4
2015 4
2017 3
2018 5
2019 5
2020 4
2021 10
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial.
Hong DS, Van Tine BA, Biswas S, McAlpine C, Johnson ML, Olszanski AJ, Clarke JM, Araujo D, Blumenschein GR Jr, Kebriaei P, Lin Q, Tipping AJ, Sanderson JP, Wang R, Trivedi T, Annareddy T, Bai J, Rafail S, Sun A, Fernandes L, Navenot JM, Bushman FD, Everett JK, Karadeniz D, Broad R, Isabelle M, Naidoo R, Bath N, Betts G, Wolchinsky Z, Batrakou DG, Van Winkle E, Elefant E, Ghobadi A, Cashen A, Grand'Maison A, McCarthy P, Fracasso PM, Norry E, Williams D, Druta M, Liebner DA, Odunsi K, Butler MO. Hong DS, et al. Among authors: betts g. Nat Med. 2023 Jan;29(1):104-114. doi: 10.1038/s41591-022-02128-z. Epub 2023 Jan 9. Nat Med. 2023. PMID: 36624315 Free PMC article. Clinical Trial.
Regulating the immune response to tumours.
Betts GJ, Clarke SL, Richards HE, Godkin AJ, Gallimore AM. Betts GJ, et al. Adv Drug Deliv Rev. 2006 Oct 1;58(8):948-61. doi: 10.1016/j.addr.2006.05.006. Epub 2006 Aug 17. Adv Drug Deliv Rev. 2006. PMID: 17070961 Review.
Improved survival prediction for oropharyngeal cancer beyond TNMv8.
Price JM, West CM, Mistry HB, Betts G, Bishop P, Kennedy J, Dixon L, Homer JJ, Garcez KP, Lee LW, McPartlin A, Sykes AJ, Thomson DJ. Price JM, et al. Among authors: betts g. Oral Oncol. 2021 Apr;115:105140. doi: 10.1016/j.oraloncology.2020.105140. Epub 2021 Feb 3. Oral Oncol. 2021. PMID: 33548862
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer.
Price JM, Mistry HB, Betts G, Cheadle EJ, Dixon L, Garcez K, Illidge T, Iyizoba-Ebozue Z, Lee LW, McPartlin A, Prestwich RJD, Papageorgiou S, Pritchard DJ, Sykes A, West CM, Thomson DJ. Price JM, et al. Among authors: betts g. J Clin Oncol. 2022 Jul 10;40(20):2203-2212. doi: 10.1200/JCO.21.01991. Epub 2022 Apr 6. J Clin Oncol. 2022. PMID: 35385334 Free PMC article.
Gene expression patterns in adenoid cystic carcinoma with and without diffuse NOTCH1 intracellular domain (NICD1) immunohistochemistry staining.
Patel K, Manzo M, Hapuarachi B, Rack S, Jermann P, Feeney L, Heathcote E, Betts G, Aster JC, Murone M, Bobadilla M, Lehal R, Vogl FD, Harrington K, Metcalf R. Patel K, et al. Among authors: betts g. Oral Oncol. 2023 Nov;146:106542. doi: 10.1016/j.oraloncology.2023.106542. Epub 2023 Aug 22. Oral Oncol. 2023. PMID: 37619521 No abstract available.
111 results